Biotechnology Industry — Sector Outlook & Stocks

The Biotechnology industry on FinBizNet covers 8 listed companies, with broker-view summaries, sub-industry segmentation, latest quarterly results and peer comparisons for each constituent.

Biotechnology industry at a glance

Listed companies8
Combined market cap₹64,408 Cr
Median P/E (profitable companies)35.7
Median return on equity-1.0%
Companies with latest quarterly results5 of 8

Companies in the Biotechnology industry

CompanyMarket CapP/EROEQuarterly RevenueQuarterly Net ProfitQuarter
Biocon Limited₹59,929 Cr131.21.1%₹4,389 Cr₹57 CrQ2 FY27
Panacea Biotec Ltd.₹2,166 Cr—-0.9%₹190 Cr₹12 CrQ2 FY27
Hester Biosciences Ltd₹1,985 Cr35.716.6%₹98 Cr₹21 CrQ2 FY27
Zenotech Laboratories Ltd₹241 Cr—-1.1%———
Bharat Immunologicals & Biologics Ltd₹39 Cr—-17.2%₹0 Cr₹-5 CrQ3 FY23
Nirman Agri Genetics Limited₹21 Cr1.214.8%———
Transgene Biotek Ltd.₹19 Cr—-18.0%₹0 Cr₹-0 CrQ1 FY27
Hindustan Bio Sciences Ltd₹7 Cr—-9.1%———

Market data from the FinBizNet stock universe; quarterly figures in ₹ crore, parsed from each company's exchange filing (XBRL).

Sub-industries within Biotechnology

Frequently Asked Questions

Which stocks are in the Biotechnology industry?

FinBizNet tracks 8 listed companies in the Biotechnology industry: Biocon Limited, Panacea Biotec Ltd., Hester Biosciences Ltd, Zenotech Laboratories Ltd, Bharat Immunologicals & Biologics Ltd, Nirman Agri Genetics Limited, Transgene Biotek Ltd., Hindustan Bio Sciences Ltd.

What are the largest Biotechnology companies by market capitalisation?

By market capitalisation, the largest Biotechnology companies are Biocon Limited (₹59,929 Cr), Panacea Biotec Ltd. (₹2,166 Cr), Hester Biosciences Ltd (₹1,985 Cr), Zenotech Laboratories Ltd (₹241 Cr), Bharat Immunologicals & Biologics Ltd (₹39 Cr).

What is the combined market capitalisation of the Biotechnology industry?

The 8 Biotechnology companies tracked on FinBizNet have a combined market capitalisation of about ₹64,408 Cr.

What is the median P/E ratio in the Biotechnology industry?

The median price-to-earnings ratio across 3 profitable Biotechnology companies is 35.7, and the median return on equity across the industry is -1.0%. Medians are shown for context only.

What does FinBizNet cover for the Biotechnology industry?

FinBizNet aggregates broker research, sub-industry breakdowns, quarterly results and peer-stock comparisons across the Biotechnology industry.